MCMarie-Caroline Cotel

Marie-Caroline Cotel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marie-Caroline Cotel has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Contrasting effects of chronic lithium, haloperidol and olanzapine exposure on synaptic clusters in the rat prefrontal cortex

    by Els F. Halff, Marie-Caroline Cotel, Sridhar Natesan, Richard McQuade, Chris J. Ottley, Deepak P. Srivastiva, Oliver D. Howes, Anthony C. Vernon

    The pathophysiology of the majority of neuropsychiatric disorders, including schizophrenia and mood disorders, involves synaptic dysfunction and/or loss, manifesting as lower levels of several presynaptic and postsynaptic marker proteins. Whether chronic exposure to antipsychotic drugs may contribute to this pattern of synaptic loss remains controversial. In contrast, the mood stabiliser lithium has shown to exhibit neurotrophic actions and is thought to enhance synapse formation. Whilst these data are not unequivocal, they suggest that antipsychotic drugs and lithium have contrasting effects on synapse density. We therefore investigated the effect of chronic exposure to lithium and to two different antipsychotics, haloperidol and olanzapine, on presynaptic Synaptic Vesicle glycoprotein 2A (SV2A) and postsynaptic Neuroligin (NLGN) clusters in the rat frontal cortex. Chronic exposure (28 days) to haloperidol (0.5 mg/kg/d) or olanzapine (7.5 mg/kg/d) had no effect on either SV2A or NLGN clusters and no overall effect on synaptic clusters. In contrast, chronic lithium exposure (2 mmol/L eq./d) significantly increased NLGN cluster density as compared to vehicle, but did not affect either SV2A or total synaptic clusters. These data are consistent with and extend our prior work, confirming no effect of either antipsychotics or lithium on SV2A clustering, but suggest contrasting effects of these drugs on the post-synapse. Although caution needs to be exerted when extrapolating results from animals to patients, these data provide clarity with regard to the effect of antipsychotics and lithium on synaptic markers, thus facilitating discrimination of drug from illness effects in human studies of synaptic pathology in psychiatric disorders.


  • Top Cited Papers
    Open Access

    Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

    by Ellis Chika Onwordi, Els F. Halff, Thomas Whitehurst, Ayla Mansur, Marie-Caroline Cotel, Lisa Wells, Hannah Creeney, David Bonsall, Maria Rogdaki, Ekaterina Shatalina, et al.

    Synaptic dysfunction is hypothesised to play a key role in schizophrenia pathogenesis, but this has not been tested directly in vivo. Here, we investigated synaptic vesicle glycoprotein 2A (SV2A) levels and their relationship to symptoms and structural brain measures using [11C]UCB-J positron emission tomography in 18 patients with schizophrenia and 18 controls. We found significant group and group-by-region interaction effects on volume of distribution (VT). [11C]UCB-JVTwas significantly lower in the frontal and anterior cingulate cortices in schizophrenia with large effect sizes (Cohen’sd = 0.8-0.9), but there was no significant difference in the hippocampus. We also investigated the effects of antipsychotic drug administration on SV2A levels in Sprague-Dawley rats using western blotting, [3H]UCB-J autoradiography and immunostaining with confocal microscopy, finding no significant effects on any measure. These findings indicate that there are lower synaptic terminal protein levels in schizophrenia in vivo and that antipsychotic drug exposure is unlikely to account for them.


  • Open Access

    Region-specific and dose-specific effects of chronic haloperidol exposure on [ 3 H]-Flumazenil and [ 3 H]-Ro15-4513 GABA A receptor binding sites in the rat brain

    by Alba Peris-Yague, Amanda Kiemes, Diana Cash, Marie-Caroline Cotel, Nisha Singh, Anthony C. Vernon, Gemma Modinos

    Post-mortem studies suggest that schizophrenia is associated with abnormal expression of specific GABA A receptor (GABA A R) α subunits, including α5GABA A R. Positron emission tomography (PET) measures of GABA A R availability in schizophrenia, however, have not revealed consistent alterations in vivo . Animal studies using the GABA A R agonist [ 3 H]-muscimol provide evidence that antipsychotic drugs influence GABA A R availability, in a region-specific manner, suggesting a potential confounding effect of these drugs. No such data, however, are available for more recently developed subunit-selective GABA A R radioligands. To address this, we therefore combined a rat model of clinically relevant antipsychotic drug exposure with quantitative receptor autoradiography. Haloperidol (0.5 and 2 mg/kg/day) or drug vehicle were administered continuously to adult male Sprague-Dawley rats via osmotic mini-pumps for 28 days. Quantitative receptor autoradiography was then performed post-mortem using the GABA A R subunit-selective radioligand [ 3 H]-Ro15-4513 and the non-subunit selective radioligand [ 3 H]-flumazenil. Chronic haloperidol exposure increased [ 3 H]-Ro15-4513 binding in the CA1 sub-field of the rat dorsal hippocampus (pd = +1.3), which was not dose-dependent. [ 3 H]-flumazenil binding also increased in most rat brain regions (pA R radioligands and is the first to demonstrate a potential effect of haloperidol on the binding of a α1/5GABA A R-selective radioligand. Although caution should be exerted when extrapolating results from animals to patients, our data support a view that exposure to antipsychotics may be a confounding factor in PET studies of GABA A R in the context of schizophrenia.


  • Open Access

    The Psychiatric Risk Gene NT5C2 Regulates Adenosine Monophosphate-Activated Protein Kinase Signaling and Protein Translation in Human Neural Progenitor Cells

    by Rodrigo R.R. Duarte, Nathaniel D. Bachtel, Marie-Caroline Côtel, Sang H. Lee, Sashika Selvackadunco, Iain A. Watson, Gary A. Hovsepian, Claire Troakes, Gerome D. Breen, Douglas F. Nixon, et al.


  • Open Access

    Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue

    by Anita Calevro, Marie-Caroline Cotel, Sridhar Natesan, Michel Modo, Anthony C. Vernon, Valeria Mondelli


  • Effects of antipsychotic treatment on macrophagic activation in the adipose tissue

    by Valeria Mondelli, Anita Calevro, Marie-Caroline Cotel, Shitij Kapur, Carmine M. Pariante, Anthony Vernon

  • Open Access

    Chronic exposure to haloperidol and olanzapine leads to common and divergent shape changes in the rat hippocampus in the absence of grey-matter volume loss

    by W. R. Crum, F. Danckaers, T. Huysmans, M.-C. Cotel, S. Natesan, M. M. Modo, J. Sijbers, S. C. R. Williams, S. Kapur, A. C. Vernon

    Background: One of the most consistently reported brain abnormalities in schizophrenia (SCZ) is decreased volume and shape deformation of the hippocampus. However, the potential contribution of chronic antipsychotic medication exposure to these phenomena remains unclear.Method: We examined the effect of chronic exposure (8 weeks) to clinically relevant doses of either haloperidol (HAL) or olanzapine (OLZ) on adult rat hippocampal volume and shape using ex vivo structural MRI with the brain retained inside the cranium to prevent distortions due to dissection, followed by tensor-based morphometry (TBM) and elastic surface-based shape deformation analysis. The volume of the hippocampus was also measured post-mortem from brain tissue sections in each group.Results: Chronic exposure to either HAL or OLZ had no effect on the volume of the hippocampus, even at exploratory thresholds, which was confirmed post-mortem. In contrast, shape deformation analysis revealed that chronic HAL and OLZ exposure lead to both common and divergent shape deformations (q = 0.05, FDR-corrected) in the rat hippocampus. In particular, in the dorsal hippocampus, HAL exposure led to inward shape deformation, whereas OLZ exposure led to outward shape deformation. Interestingly, outward shape deformations that were common to both drugs occurred in the ventral hippocampus. These effects remained significant after controlling for hippocampal volume suggesting true shape changes.Conclusions: Chronic exposure to either HAL or OLZ leads to both common and divergent effects on rat hippocampal shape in the absence of volume change. The implications of these findings for the clinic are discussed.


  • Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses

    by Marie-Caroline Cotel, Ewelina M. Lenartowicz, Sridhar Natesan, Michel M. Modo, Jonathan D. Cooper, Steven C.R. Williams, Shitij Kapur, Anthony C. Vernon